About

About Imagene AI Imagene AI is a pioneer in multimodal foundation models for precision medicine, advancing translational research and clinical development. Our Cross-Modality Intelligence Engine, delivered through the OI Suite, integrates real-world data including histopathology images, multi-omic data, longitudinal clinical records to derive meaningful, biologically grounded insights, generate and validate biomarker hypotheses, and increase predictive power in low-data settings. We make every trial more responsive, every insight more actionable, and every patient journey more personalized. Founded in 2020 and backed by leading investors including Larry Ellison, and advised by world-leading oncologists on our Scientific Advisory Board, Imagene AI has been recognized with the Pharmaceutical Technology Excellence Award and the Digital Health Innovation Award as one of the Top 25 Healthcare AI Companies of 2025.